Clinical Trial Update: Oltipraz in the Prevention of Lung Cancer in People Who Smoke [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating oltipraz for lung cancer prevention in people who smoke has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Oltipraz (oltipraz)

Snippet

Sponsor: Northwestern University | Conditions: Lung Cancer | Phase 1 | Status: COMPLETED